http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014151013-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C307-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C307-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C307-08 |
| filingDate | 2013-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014151013-A |
| titleOfInvention | NEW INDANESULFAMIDE DERIVATIVE |
| abstract | 1. The compound, or a pharmaceutically acceptable salt thereof, selected from the group consisting of: 1) N - [(1S) -2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl] sulfamide, 2) N - [(1S) -2,2,4,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl] sulfamide, 3) (+) - N- (2,2, 4,6,7-pentafluoro-2,3-dihydro-1H-inden-1-yl) sulfamide, 4) N - [(1S *) - 5-cyano-2,2-difluoro-7-methyl-2, 3-dihydro-1H-inden-1-yl] sulfamide, 5) (-) - N- (7-chloro-2,2,5-trifluoro-2,3-dihydro-1H-inden-1-yl) sulfamide 6) (-) - N- (7-chloro-2,2,4-trifluoro-2,3-dihydro-1H-inden-1-yl) sulfamide; 7) (-) - N- (7-chlorine -2,2-difluoro-2,3-dihydro-1H-inden-1-yl) sulfamide, 8) (-) - N- (7-chloro-2,2,6-trifluoro-2,3-dihydro- 1H-inden-1-yl) sulfamide, 9) (+) - N- (5-x op-2,2,7-trifluoro-2,3-dihydro-1H-inden-1-yl) sulfamide, 10) N - [(1S) -2,2-difluoro-7-methyl-2,3-dihydro -1H-inden-1-yl] sulfamide, 11) N - [(1S) -2,2,5-trifluoro-7-methyl-2,3-dihydro-1H-inden-1-yl] sulfamide, 12) N - [(1S *) - 2,2,4-trifluoro-7-methyl-2,3-dihydro-1H-inden-1-yl] sulfamide, 13) N - [(1S *) - 7- (difluoromethyl ) -2,2-difluoro-2,3-dihydro-1H-inden-1-yl] sulfamide, 14) N - [(1R *, 2R *) - 2,4,7-trifluoro-2,3-dihydro -1H-inden-1-yl] sulfamide, 15) (-) - N - [(1R *, 2R *) - 7-chloro-2,4-difluoro-2,3-dihydro-1H-inden-1- yl] sulfamide, 16) (+) - N - [(1R *, 2R *) - 7-chloro-2,4-difluoro-2,3-dihydro-1H-inden-1-yl] sulfamide, 17) ( -) - N - [(1R *, 2R *) - 7-chloro-2,5-difluoro-2,3-dihydro-1H-inden-1-yl] sulfamide, 18) (+) - N - [( 1R *, 2R *) - 4-chloro-7-fluoro-2-m ethoxy-2,3-dihydro-1H-inden-1-yl] sulfamide, 19) (+) - N- (7-chloro-4-fluoro-2,3-dihydro-1H-inden-1-yl) sulfamide , 20) (±) -N- (5-fluoro-7-methyl-2,3-dihydro-1H-inden-1-yl) sulfamide, 21) (-) - N- (4-fluoro-7-methyl -2,3-dihydro-1H-inden-1-yl) sulfamide, 22) (+) - N- (4-fluoro-7-methyl-2,3-dihydro-1H-inden-1-yl) sulfamide, 23) (+) - N- (7-methyl-2,3-dihydro-1H-inden-1-yl) sulfamide, 24) (±) -N- (5-chloro-7-methyl-2,3- dihydro-1H-inden-1-yl) sulfamide, 25) (-) - N- (4-chloro-7-fluoro-2,3-dihydro-1H-inden-1-yl) sulfamide, 26) (+) -N- (7-chloro-5-cyano-2,3-dihydro-1H-inden-1-yl) sulfamide, 27) (-) - N- (7-chloro-5-cyano-2,3-dihydro -1H-inden-1-yl) sulfamide, 28) (-) - N- (5-chloro-7-fluoro-2,3-dihydro-1H-inden-1-yl) s ulfamide, 29) N - [(1S) -4,7-difluoro-2,3-dihydro-1H-inden-1-yl] sulfamide, 30) (+) - N- (7-chloro-2,3- dihydro-1H-inden-1-yl) sulfamide, 31) (+) - N- (5-cyano-7-methyl-2,3-dihydro-1H-inden-1-yl) sulfamide, 32) (-) -N- (5-cyano-7-methyl-2,3-dihydro-1H-inden-1-yl) sulfamide, 33) N - [(1S) -7-chloro-5-fluoro-2,3-dihydro -1H-inden-1-yl] sulfamide 34) (-) - N- (4,6,7-trifluoro-2,3-dihydro-1H-inden-1-yl) sulfamide. 2. The compound or its pharmaceutically acceptable |
| priorityDate | 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.